SALIM VIRANI to Insurance, Health, Reimbursement
This is a "connection" page, showing publications SALIM VIRANI has written about Insurance, Health, Reimbursement.
Connection Strength
0.036
-
Updated Cost-effectiveness Assessments of PCSK9 Inhibitors From the Perspectives of the Health System and Private Payers: Insights Derived From the FOURIER Trial. JAMA Cardiol. 2017 12 01; 2(12):1369-1374.
Score: 0.036